4-(2-Hydroxyphenyl)-2-[4-(trifluoromethyl)phenyl]-thiazole, 250mg

(1-(tert-Butoxycarbonyl)-3-methyl-1H-pyrazol-5-yl)boronic acid, 95.0%, 5g

PCR individual vials Mμlti®, green, 200 µl 1000 pcs

4,6-Dimethylnicotinic acid, 95.0%, 250mg

3,5-Difluorobenzylzinc bromide 0.5 M in Tetrahydrofuran, 25ml

3-((4-(tert-butyl)phenyl)sulfonamido)benzoic acid, 95.0%, 1g

3-Methylphenanthrene>98.0%(GC)100mg

Ethyl 3-bromo-4-fluoro-2-methylbenzoate, 95%, 250mg

2-Amino-5-bromo-3-hydroxypyridine>98.0%(HPLC)1g

2-(Trifluoromethyl)benzyl bromide, 98.0%, 25g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)amino)-2-methylhexanoic acid, 97%, 1g

(9H-Fluoren-9-yl)methyl tert-butyl ethane-1,2-diyldicarbamate, 97.0%, 250mg

4-Chloro-3-[(3-methylpiperidin-1-yl)sulfonyl]benzoic acid, 97%, 100mg